ArticleJournal for immunotherapy of cancer2023

Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.

Liang Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.